hims retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam How Retatrutide Put Him In

Combining retatrutide with insulin or sulfonylureas significantly increases the risk of hypoglycaemia and may require dose adjustments

At higher doses, people saw an average weight loss of around 5% of their total body weight during the first month

A CDC review of six-month lifestyle programs found they produced roughly 5.7 pounds more weight loss than control groups, which can improve health markers

Because Truveta Data is updated daily, we can show the latest trends in these medications

Modified BRAT for weight loss: Add protein to prevent muscle loss

Dahl D, Onishi Y, Norwood P et al (2022) Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial